Long-term follow-up for people in the HIV-NAT studies
Part of Immune system & allergy, Infections clinical trials.
This study checks in with people who have joined HIV-NAT research in the past or are joining it now, to learn how their HIV and treatment outcomes look over time. It may help improve future care and research for people living with HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have HIV, and you participated in an HIV-NAT study before
- Or you are currently participating in an HIV-NAT trial
- You can sign a written consent form
- This study is for both children and adults
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study (not a new drug) that tracks how living with HIV can change over time in different treatment situations. It may help researchers understand long-term effects of the modern “protease inhibitor era” and improve future care.
This is an observational study that follows people to better understand how HIV and other infections (like sexually transmitted infections) happen and change over time. It may help researchers improve prevention and care, but it is mainly for monitoring rather than testing a new treatment.
This is an observational study that follows people with HIV who are taking HIV medicines (antiretroviral therapy). It may help researchers understand how treatment is going and what factors relate to doing well on therapy.
This trial tests a new type of medicine that aims to wake up HIV hiding in your body's cells by targeting a viral protein called Tat. The goal is to help find a way to clear the virus completely.
This study enrolls adults with a very recent (“acute”) HIV infection to follow them over time and better understand what happens early after infection. Your participation may help researchers improve how acute HIV is detected and managed.
This Phase 3 study looks at antiretroviral treatment (HIV medicines) for adults with either recent (acute) or long-term (chronic) HIV. It’s designed to see how well and safely ongoing HIV treatment works, and it may help you get structured care and monitoring.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.